Literature DB >> 31828685

Emergence of multidrug resistance among Haemophilus parainfluenzae from respiratory and urogenital samples in Barcelona, Spain.

Yanik Sierra1, Aida González-Díaz1,2, Fe Tubau1,2, Arkaitz Imaz3, Meritxell Cubero1,2, Jordi Càmara1,2, Josefina Ayats1, Sara Martí4,5, Carmen Ardanuy6,7,8.   

Abstract

Haemophilus parainfluenzae (HPAR) is a Gram-negative bacterium that can become an opportunistic urogenital pathogen. Recently, multidrug resistant (MDR) strains have emerged. We aim to analyse the epidemiology of HPAR at Hospital Universitari de Bellvitge between 2013 and 2017 to determine its putative role in sexually transmitted infections (STI). Strains were classified by sample origin, and antimicrobial susceptibility was performed by disk-diffusion tested on Mueller-Hinton Fastidious. MDR was defined as the resistance of the antimicrobial to three or more antibiotic class. Molecular typing was performed by pulsed-field gel electrophoresis (PFGE) after restriction with SmaI and Cfr9I. We classified 944 HPAR isolates as being of urogenital (n = 175; 18.5%), respiratory (n = 719; 76.2%), or other (n = 50; 5.3%) origins. Among the urogenital isolates, 50 (28.6%) were MDR, which was significantly higher than that found in respiratory samples (40/719; 5.6%; p < 0.01). The frequency of MDR increased progressively among urogenital samples from 13.3% (2013) to 33.3% (2017) (r = 0.8; p = 0.035). The resistance rates for all 944 episodes were significantly higher for cotrimoxazole (51.4%), tetracycline (46.3%), chloramphenicol (28.0%), ciprofloxacin (21.1%), and ampicillin (20.6%). After PFGE, no clonal relationship was found. Clinical charts were available for 40 symptomatic patients with MDR HPAR infections presenting mostly urethritis (n = 26; 65.0%). In all cases, symptoms were treated effectively with combination therapy. Furthermore, in 10 of those patients with urethritis, MDR HPAR was the only potential pathogen to be identified. The emergence of MDR HPAR is a matter of concern, and the detection as a single pathogen highlights its putative role as cause of STI.

Entities:  

Keywords:  Emergence; Epidemiology; Haemophilus parainfluenzae; Multidrug resistance; Sexually transmitted infection; Urogenital

Year:  2019        PMID: 31828685     DOI: 10.1007/s10096-019-03774-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  38 in total

1.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

Authors:  A-P Magiorakos; A Srinivasan; R B Carey; Y Carmeli; M E Falagas; C G Giske; S Harbarth; J F Hindler; G Kahlmeter; B Olsson-Liljequist; D L Paterson; L B Rice; J Stelling; M J Struelens; A Vatopoulos; J T Weber; D L Monnet
Journal:  Clin Microbiol Infect       Date:  2011-07-27       Impact factor: 8.067

2.  Molecular characterization of a clinical Haemophilus parainfluenzae isolate with cefotaxime resistance and decreased susceptibility to fluoroquinolones.

Authors:  Diego Faccone; Paula Lopez-Ruitti; Miryam Vazquez; Leonor Guerriero; Celeste Lucero; Paula Gagetti; Paola Ceriana; Alejandra Corso
Journal:  Infect Genet Evol       Date:  2016-08-05       Impact factor: 3.342

3.  Genetic detection of quinolone resistance in Haemophilus parainfluenzae: Mutations in the quinolone resistance-determining regions of gyrA and parC.

Authors:  Dennis Ks Law; Michelle Shuel; Sadjia Bekal; Elizabeth Bryce; Raymond Sw Tsang
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

4.  Isolation of Haemophilus influenzae and Haemophilus parainfluenzae in urethral exudates from men with acute urethritis: a descriptive study of 52 cases.

Authors:  Gustavo Deza; Gemma Martin-Ezquerra; Julià Gómez; Judit Villar-García; August Supervia; Ramon M Pujol
Journal:  Sex Transm Infect       Date:  2015-07-02       Impact factor: 3.519

5.  Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates.

Authors:  Carmen Puig; José Manuel Tirado-Vélez; Laura Calatayud; Fe Tubau; Junkal Garmendia; Carmen Ardanuy; Sara Marti; Adela G de la Campa; Josefina Liñares
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.191

6.  Molecular Characterization of Fluoroquinolone-Resistant Haemophilus parainfluenzae Clinical Isolates in Spain.

Authors:  Inmaculada López-Hernández; Jesús Machuca; Paula Díaz de Alba; Carolina Sarvisé; Frederic Gómez; José Manuel Rodríguez-Martínez; Alvaro Pascual
Journal:  Microb Drug Resist       Date:  2017-04-17       Impact factor: 3.431

7.  Novel mechanisms of resistance to β-lactam antibiotics in Haemophilus parainfluenzae: β-lactamase-negative ampicillin resistance and inhibitor-resistant TEM β-lactamases.

Authors:  S García-Cobos; M Arroyo; J Campos; M Pérez-Vázquez; B Aracil; E Cercenado; B Orden; N Lara; J Oteo
Journal:  J Antimicrob Chemother       Date:  2013-01-18       Impact factor: 5.790

8.  Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain.

Authors:  Jordi Cámara; Judit Serra; Josefina Ayats; Teresa Bastida; Dolors Carnicer-Pont; Antònia Andreu; Carmen Ardanuy
Journal:  J Antimicrob Chemother       Date:  2012-05-07       Impact factor: 5.790

9.  Haemophilus parainfluenzae Mural Endocarditis: Case Report and Review of the Literature.

Authors:  Luca T Giurgea; Tim Lahey
Journal:  Case Rep Infect Dis       Date:  2016-06-12

10.  Nasopharyngeal and Adenoid Colonization by Haemophilus influenzae and Haemophilus parainfluenzae in Children Undergoing Adenoidectomy and the Ability of Bacterial Isolates to Biofilm Production.

Authors:  Urszula Kosikowska; Izabela Korona-Głowniak; Artur Niedzielski; Anna Malm
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

View more
  2 in total

1.  Pathogen Metagenomics Reveals Distinct Lung Microbiota Signatures Between Bacteriologically Confirmed and Negative Tuberculosis Patients.

Authors:  Li Ding; Yanmin Liu; Xiaorong Wu; Minhao Wu; Xiaoqing Luo; Hui Ouyang; Jinyu Xia; Xi Liu; Tao Ding
Journal:  Front Cell Infect Microbiol       Date:  2021-09-13       Impact factor: 5.293

2.  Gut Microbiota Dysbiosis Correlates with Abnormal Immune Response in Moderate COVID-19 Patients with Fever.

Authors:  Yaya Zhou; Xing Shi; Wei Fu; Fei Xiang; Xinliang He; Bohan Yang; Xiaorong Wang; Wan-Li Ma
Journal:  J Inflamm Res       Date:  2021-06-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.